Trial Profile
Clinical Trials Insight: 700047464
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Aug 2009
Price :
$35
*
At a glance
- Drugs Telatinib (Primary) ; Capecitabine; Irinotecan
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Bayer
- 03 Aug 2009 New trial record.